Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer
Abstract Background Breast cancer is the second most common cancer worldwide, the most common among women, and the most frequent cause of death among women in less developed regions. Trastuzumab is a humanized monoclonal antibody that downregulates the extracellular domain of the HER2 protein. Using...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2019-02-01
|
| coleção: | Cost Effectiveness and Resource Allocation |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s12962-019-0174-7 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|